Roche's drug candidate for Multiple Sclerosis touted to be better than Merck’s Rebif The much anticipated multiple sclerosis drug from Roche, ocrelizumab, has overtaken Merck’s Rebif according to t...
Targeted treatment can become a reality for esophageal cancer, as a study opens door A group of researchers Scientists, funded by Cancer Research UK and Medical Research Council, have discovered that oesophageal cancer can be classified into three different subtypes, paving the way for testing targeted treatments ta...
Find MoreThere has been a shocking revelation in a report published in Science Translational Medicine by Bengt Westermark, a tumour biologist at Uppsala, who reports that a cell line widely used to study brain cancer does not match the cells used to create the line nearly 50 years ago, or the tumour supposed to be its source...
Find MoreBoehringer Ingelheim Pharmaceuticals and the Duke Clinical Research Institute have expanded their collaboration to create the largest patient registry for Idiopathic Pulmonary Fibrosis (IPF) The IPF-PRO Registry will be widened to cover 1500 patients spread over 45 clinical sites which will stimulate understand...
Find MoreThe South San Francisco biotech startup, Denali Therapeutics, that had raised $217 million last year to fight Alzheimer’s, Parkinson’s and ALS, and an additional $130 million from investors in a private placement led by Baillie Gifford, a UK-based mutual fund, has finally spoken about its plans to use the fund. The...
Find MoreNATCO Pharma surges 7% post successful Establishment Inspection Report for Chennai Plant NATCO pharma has reached a new high of Rs. 703 on the National Stock Exchange (NSE) as the drug maker revealed the successful Establishment Inspection Report (EIR) for Chennai Plant. The U.S. Food and Drug Administration (FDA) h...
Find MoreFatty acid amide hydrolase (FAAH) is an intracellular amidase signature family of serine hydrolases enzyme, which catalyzes the hydrolysis of bioactive fatty acid ethanolamides such as anandamide and oleoylethanolamide. FAAH serves as the major metabolic regulator of many of the endogenous fatty acid amides, exhibit...
Find MoreGene Therapy: The “Hunt” for CNS disorders! Many companies have tried over the years to find a way to reverse the course of crippling central nervous system disorders like amyotrophic lateral sclerosis (a.k.a. Lou Gehrig’s disease) but have failed. Fortunately, Gene therapy has proven to be an answer to a wide ran...
Find MoreDelveInsight’s,“ Brain Hemorrhage-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Brain Hemorrhage. This report provides information on the therapeu...
Find MoreAccording to WHO, Chronic Obstructive Pulmonary Disease (COPD) is the third leading cause of death g.....
Find MoreImmune thrombocytopenic purpura (ITP) is a disorder that results in the immune system killing its pl.....
Find MoreThe medical device industry is experiencing rapid change as innovation is accelerating, new business.....
Find MorePostoperative Pain is the pain that an individual experiences after a major operation or surgical pr.....
Find MoreOver the years, the Oncology domain has experienced the entry of several treatment approaches. Thera.....
Find MoreMarket intelligence (MI) is described as the information or the data derived by a company from the m.....
Find MoreThe American Society of Clinical Oncology (ASCO) is one of the largest and most respected conferences in the field of oncology. Held annually, this conference brings together researchers, physicians, and other healthcare professionals from around the world to discuss the latest advances in cancer research, diagnosis, and treatment.